Cargando…

Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines

The involvement of proteoglycans (PGs) in EBV-host interactions and lymphomagenesis remains poorly investigated. In this study, expression of major proteoglycans (syndecan-1, glypican-1, perlecan, versican, brevican, aggrecan, NG2, serglycin, decorin, biglycan, lumican, CD44), heparan sulphate (HS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsidulko, Alexandra Y., Matskova, Liudmila, Astakhova, Lidiia A., Ernberg, Ingemar, Grigorieva, Elvira V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791248/ https://www.ncbi.nlm.nih.gov/pubmed/26527314

Ejemplares similares

Short Chain Fatty Acids (SCFA) Reprogram Gene Expression in Human Malignant Epithelial and Lymphoid Cells
por: Astakhova, Lidiia, et al.
Publicado: (2016)

Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells
por: Gainullin, Murat R., et al.
Publicado: (2017)

Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer
por: Suhovskih, Anastasia V., et al.
Publicado: (2014)

Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo
por: Tsidulko, Alexandra Y., et al.
Publicado: (2018)

Glucocorticoid Effects on Proteoglycans and Glycosaminoglycans
por: Strokotova, Anastasia V., et al.
Publicado: (2022)

Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma
por: Zheng, Shixing, et al.
Publicado: (2020)

MTSS1 is downregulated in nasopharyngeal carcinoma (NPC) which disrupts adherens junctions leading to enhanced cell migration and invasion
por: Zheng, Shixing, et al.
Publicado: (2023)

Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca(2+)/calpain/ITGβ4 axis
por: Liang, Jiezhen, et al.
Publicado: (2017)

Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes
por: Su, Zhendong, et al.
Publicado: (2017)

What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype
por: Hayes, Anthony J., et al.
Publicado: (2021)

Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies
por: Choi, Chung King, et al.
Publicado: (2015)

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies
Publicado: (1992)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients
por: Friis, Anna M. C., et al.
Publicado: (2010)

EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies
por: Williams, Marshall V., et al.
Publicado: (2023)

miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues
por: Prudnikova, Tatiana Y., et al.
Publicado: (2012)

Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma
por: Wang, Zifeng, et al.
Publicado: (2016)

Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors
por: Suhovskih, Anastasia V., et al.
Publicado: (2020)

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2020)

Proteoglycan Expression in Normal Human Prostate Tissue and Prostate Cancer
por: Suhovskih, Anastasia V., et al.
Publicado: (2013)

The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies
por: Chatterjee, Koustav, et al.
Publicado: (2019)

Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome.
por: Kotler, M., et al.
Publicado: (1979)

Molecular Epidemiology of Epstein-Barr virus (EBV) in Patients with Hematologic Malignancies
por: Tabibzadeh, Alireza, et al.
Publicado: (2020)

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies
por: Zhang, Xi, et al.
Publicado: (2023)

Mechanisms of Anergic Inflammatory Response in Nasopharyngeal Carcinoma Cells Despite Ubiquitous Constitutive NF-κB Activation
por: Zhou, Xiaoying, et al.
Publicado: (2022)

Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines
por: Relan, Vandana, et al.
Publicado: (2013)

Epigenetic downregulation of the ISG15–conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma
por: Zhou, Xiaoying, et al.
Publicado: (2015)

DNA ploidy, cell proliferation, and HIV/EBV association in Tanzanian malignant lymphomas
por: Mwakigonja, Amos, et al.
Publicado: (2010)

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
por: Haverkos, Bradley, et al.
Publicado: (2023)

Malignant cancer and invasive placentation: A case for positive pleiotropy between endometrial and malignancy phenotypes
por: D'Souza, Alaric W., et al.
Publicado: (2014)

Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association
por: Mwakigonja, Amos R, et al.
Publicado: (2010)

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies
por: Li, Hongde, et al.
Publicado: (2018)

Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
por: Shechter, Oren, et al.
Publicado: (2022)

Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis
por: Abusalah, Mai Abdel Haleem, et al.
Publicado: (2022)

Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection
por: Grützmeier, Sven, et al.
Publicado: (2016)

The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Three-Dimensional Models as a New Frontier for Studying the Role of Proteoglycans in the Normal and Malignant Breast Microenvironment
por: Clegg, Julien, et al.
Publicado: (2020)

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
por: Mertowska, Paulina, et al.
Publicado: (2023)

Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma.
por: Saito, T., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_tgfqo1d9u7h4ekap8o1ka1euu1